About imunoglobulin
Human normal immunoglobulin (IVIG)
Used for
- Replacement treatment for primary or secondary antibody deficiency
- Immune thrombocytopenia
- Chronic inflammatory demyelinating polyneuropathy
- Other immune conditions, depending on local approval
Usual adult dose
Varies by condition: commonly 0.2–0.4 g/kg every 3–4 weeks for antibody deficiency; other conditions use higher courses.
Usual dose in children
For antibody deficiency, commonly 0.2–0.8 g/kg every 3–4 weeks; condition-specific regimens vary.
Common side effects
- Headache, chills, fever, or flushing
- Nausea, vomiting, or muscle pain
- Infusion reactions, including changes in blood pressure
- Rare kidney injury, blood clots, or severe allergic reactions
Important warnings
- Infusion must be supervised by healthcare professionals.
- Risk of blood clots, especially with risk factors or rapid infusion.
- May cause kidney problems or red blood cell breakdown.
- Contains maltose; some glucose tests may show falsely high results.
Pregnancy
Use only when clinically needed; pregnancy experience is limited, and treatment decisions require medical assessment.
Breastfeeding
Immunoglobulin is present naturally in breast milk; treatment is generally considered compatible with breastfeeding.
Interactions
- Live vaccines, including measles, mumps, rubella, and varicella, may be less effective for months afterward.
- May interfere with laboratory tests, including some glucose measurements.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.